HomeRMTI • NASDAQ
add
Rockwell Medical Inc
Previous close
$2.20
Day range
$2.18 - $2.31
Year range
$1.16 - $5.15
Market cap
72.72M USD
Avg Volume
906.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 28.32M | 19.12% |
Operating expense | 4.30M | 9.24% |
Net income | 1.66M | 188.89% |
Net profit margin | 5.88 | 174.62% |
Earnings per share | — | — |
EBITDA | 2.48M | 311.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.27M | 55.77% |
Total assets | 57.08M | 8.51% |
Total liabilities | 27.95M | -10.10% |
Total equity | 29.14M | — |
Shares outstanding | 32.32M | — |
Price to book | 2.44 | — |
Return on assets | 8.79% | — |
Return on capital | 11.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 1.66M | 188.89% |
Cash from operations | 4.28M | 213.91% |
Cash from investing | -6.11M | 40.61% |
Cash from financing | 2.31M | -81.99% |
Net change in cash | 475.00K | 139.58% |
Free cash flow | 3.11M | 407.60% |
About
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease.
The company's primary customers are dialysis providers. Wikipedia
Founded
1996
Headquarters
Website
Employees
237
